发明名称 FUSED PYRIDAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT
摘要 <p>Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). &lt;CHEM&gt; Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.</p>
申请公布号 EP1477175(A1) 申请公布日期 2004.11.17
申请号 EP20030705265 申请日期 2003.02.18
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 SEKO, TAKUYA;TAKEUCHI, JUN;TAKAHASHI, SHINYA;KAMANAKA, YOSHIHISA;KAMOSHIMA, WATARU
分类号 C07D237/32;A61K31/501;A61K31/502;A61K31/5025;A61K31/53;A61K31/5377;A61K31/541;A61K31/542;A61K31/55;A61K31/551;A61K31/554;A61P13/12;A61P3/10;A61P7/08;A61P9/00;A61P9/10;A61P25/00;A61P27/06;A61P29/00;A61P31/12;A61P31/18;A61P35/00;A61P37/06;A61P43/00;C07D237/26;C07D401/06;C07D401/12;C07D403/06;C07D403/12;C07D405/06;C07D405/12;C07D409/12;C07D417/12;C07D471/04;C07D487/04;C07D513/04;(IPC1-7):C07D237/32;A61K31/537 主分类号 C07D237/32
代理机构 代理人
主权项
地址